ThinkSabio

$AGMB

$12.28▲ -6.0% YTD

3 SEC 13D/G filings tracked · Last updated Sep 14, 2026

Filing History
News
AGMB ▼ -6.0% - AgomAb Therapeutics NV
CP $12.28▲ -6.0%Sep 14, 2026 · ThinkSabio Blog

$AGMB - Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study…

News
AGMB ▼ -8.1% - AgomAb Therapeutics NV
CP $12.81▲ -8.1%Sep 11, 2026 · ThinkSabio Blog

$AGMB - Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors…

News
AGMB ▲ +8.6% - AgomAb Therapeutics NV
CP $14.83▲ +8.6%Sep 3, 2026 · ThinkSabio Blog

$AGMB - Agomab to Participate in Upcoming Investor Conferences…